Despite low volatility in the domestic stock markets over the past few months, investors are expected to tread cautiously ...

Domestic brokerage Nuvama Institutional Equities warned that Nifty 50's decline is due to weak earnings and high valuations, ...

The markets are in the red but there is no dearth of value buys. Here are some stocks that have significant upside potential ...

Citi's picks in India's asset management companies are 360 One, Nuvama and Prudent. While Aditya Birla Sun Life AMC Ltd's ...

BSE’s index option premium market share had earlier shot up to 22.1 per cent in February 2025 from 16.4 per cent in December ...

Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...

Given the persistent selling by global funds, Nifty recorded five consecutive months of selling - the first time in three ...

Nuvama argued that NSE's decision to shift the expiry day for its derivative contracts to Monday would lower industry volumes ...

BSE stock was trading 3.76 per cent lower to ₹4,025 apiece on March 10. The stock has plunged over 10 per cent in the last ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

NSE will change the expiry of its derivatives contracts to Monday starting April 4, potentially reducing BSE's market share ...

Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!